市場調査レポート

商品コード

1671834

過敏性腸症候群治療市場：タイプ別、適応症別、薬剤クラス別、投与経路別、流通チャネル別、地域別

Irritable Bowel Syndrome Treatment Market, By Type, By Indication, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

出版日: 2025年02月26日
発行: Coherent Market Insights
ページ情報: 英文 156 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 648,270円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,008,420円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,440,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の過敏性腸症候群治療市場は、2025年には40億4,000万米ドルと推定され、2032年には74億3,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR9.1％で成長すると予測されています。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	40億4,000万米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年 CAGR：	9.10%	2032年の価値予測	74億3,000万米ドル

図.過敏性腸症候群治療市場シェア（%）、2025年地域別

Irritable Bowel Syndrome Treatment Market-IMG1

過敏性腸症候群（IBS）は、大腸に影響を及ぼす一般的な機能性胃腸障害です。IBSは腹部のけいれん、膨満感、ガス、下痢や便秘を引き起こします。国立医学図書館の推計によると、2024年6月には、IBSは世界中で約11％の人に影響を及ぼすとされています。IBSの正確な原因は不明ですが、消化管がストレスを処理し、正常な機能と感覚を調節する方法の変化によるものと考えられています。世界の過敏性腸症候群治療市場は、IBSの有病率の上昇と効果的な治療オプションに対する需要の高まりにより、過去数年にわたって着実な成長を遂げています。

市場力学：

世界の過敏性腸症候群治療市場は、高齢者がIBSを発症しやすいことから、高齢者人口の増加によって牽引されています。国連によると、60歳以上の高齢者数は世界の2017年の9億6,200万人から2050年には21億人に増加します。さらに、IBSに対する認識の高まりと診断の向上も、この市場の成長を支えています。しかし、IBSの治療薬が承認されていないこと、新規治療薬の開発コストが高いこと、既存薬に副作用があることなどが、市場成長の阻害要因となっています。新規薬剤製剤や非薬物療法代替品の開発は、市場に有利な機会をもたらす可能性があります。

本調査の主な特徴

本レポートでは、世界の過敏性腸症候群治療市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模および複合年間成長率（CAGR%）を掲載しています。

また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

世界の過敏性腸症候群治療市場における主要企業を、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいてプロファイルしています。

本調査の対象となる主要企業には、Ironwood Pharmaceuticals, Inc.、AbbVie Inc.、Astellas Pharma, Inc.、武田薬品工業株式会社、AstraZeneca Plc.、Sebela Pharmaceuticals, Inc.、Bausch Health Companies Inc.、Theriva Biologics, Inc.、Ardelyx, Inc.、Salix Pharmaceuticals, Inc.、Mallinckrodt Pharmaceuticals、Abbott Laboratories、Lexicon Pharmaceuticals, Inc.、GSK plc、Johnson &Johnson Services, Inc.などがあります。

本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界の過敏性腸症候群治療市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

Ironwood Pharmaceuticals, Inc.
AbbVie Inc.
Astellas Pharma, Inc.
Takeda Pharmaceutical Company Limited
AstraZeneca Plc.
Sebela Pharmaceuticals, Inc.
Bausch Health Companies Inc.
Theriva Biologics, Inc.
Ardelyx, Inc.
Salix Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals, Inc.
GSK plc
Johnson & Johnson Services, Inc.

第11章アナリストの推奨事項

運命の輪
アナリストの見解
一貫した機会マップ

第12章参考文献と調査手法

参考文献
調査手法
出版社について

Product Code: CMI506

Global Irritable Bowel Syndrome Treatment Market is estimated to be valued at US$ 4.04 Bn in 2025 and is expected to reach US$ 7.43 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	US$ 4.04 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.10%	2032 Value Projection:	US$ 7.43 Bn

Figure. Irritable Bowel Syndrome Treatment Market Share (%), By Region 2025

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that affects the large intestine. IBS causes abdominal cramping, bloating, gas, and diarrhea and/or constipation. As per National Library of Medicine estimates, in June 2024, IBS affects around 11% of people worldwide. The exact causes of IBS are unknown, but it is believed to be due to changes in the way the gastrointestinal tract handles stress and regulates normal function and sensations. The global irritable bowel syndrome treatment market has been witnessing steady growth over the past few years owing to the increasing prevalence of IBS and growing demand for effective treatment options.

Market Dynamics:

The global irritable bowel syndrome treatment market is driven by the rising geriatric population, as seniors are more prone to develop IBS. According to the United Nations, the number of people aged 60 or above will increase from 962 million globally in 2017 to 2.1 billion in 2050. Moreover, growing awareness and better diagnosis of IBS are also supporting the growth of this market. However, the lack of approved drugs for IBS, high development costs of new therapies, and side effects associated with existing drugs are some of the key factors are hampering the market growth. The development of novel drug formulations and non-drug treatment alternatives can present lucrative opportunities in the market.

Key Features of the Study:

This report provides in-depth analysis of the global irritable bowel syndrome treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global irritable bowel syndrome treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Ironwood Pharmaceuticals, Inc., AbbVie Inc., Astellas Pharma, Inc., Takeda Pharmaceutical Company Limited, AstraZeneca Plc., Sebela Pharmaceuticals, Inc., Bausch Health Companies Inc., Theriva Biologics, Inc., Ardelyx, Inc., Salix Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Abbott Laboratories, Lexicon Pharmaceuticals, Inc., GSK plc, and Johnson & Johnson Services, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global irritable bowel syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Market Segmentation

By Type Insights (Revenue, USD Bn, 2020 - 2032)
- Irritable Bowel Syndrome with Constipation (IBS-C)
- Irritable Bowel Syndrome with Diarrhea (IBS-D)
- Mixed Irritable Bowel Syndrome (IBS-M)
By Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Abdominal Pain
- Bloating
- Constipation and Diarrhea
- Altered Bowel Habits
- Others
By Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Antispasmodics
- Laxatives
- Antidiarrheal Medications
- 5-HT3 Receptor Antagonists
- Guanylate Cyclase-C Agonists
- Anticholinergic
- Probiotics
- Antidepressants
- Antibiotics
- Dietary Supplements
- Others
By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Rectal
- Parenteral
By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Ironwood Pharmaceuticals, Inc.
- AbbVie Inc.
- Astellas Pharma, Inc.
- Takeda Pharmaceutical Company Limited
- AstraZeneca Plc.
- Sebela Pharmaceuticals, Inc.
- Bausch Health Companies Inc.
- Theriva Biologics, Inc.
- Ardelyx, Inc.
- Salix Pharmaceuticals, Inc.
- Mallinckrodt Pharmaceuticals
- Abbott Laboratories
- Lexicon Pharmaceuticals, Inc.
- GSK plc
- Johnson & Johnson Services, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Irritable Bowel Syndrome Treatment Market, By Type
- Global Irritable Bowel Syndrome Treatment Market, By Indication
- Global Irritable Bowel Syndrome Treatment Market, By Drug Class
- Global Irritable Bowel Syndrome Treatment Market, By Route of Administration
- Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel
- Global Irritable Bowel Syndrome Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Irritable Bowel Syndrome Treatment Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Irritable Bowel Syndrome with Constipation (IBS-C)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Irritable Bowel Syndrome with Diarrhea (IBS-D)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Mixed Irritable Bowel Syndrome (IBS-M)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Irritable Bowel Syndrome Treatment Market, By Indication, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Abdominal Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bloating
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Constipation and Diarrhea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Altered Bowel Habits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Irritable Bowel Syndrome Treatment Market, By Drug Class, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antispasmodics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antidiarrheal Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5-HT3 Receptor Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Guanylate Cyclase-C Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Anticholinergic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Probiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Dietary Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Irritable Bowel Syndrome Treatment Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rectal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Irritable Bowel Syndrome Treatment Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Ironwood Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Astellas Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca Plc.
Sebela Pharmaceuticals, Inc.
Bausch Health Companies Inc.
Theriva Biologics, Inc.
Ardelyx, Inc.
Salix Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals, Inc.
GSK plc
Johnson & Johnson Services, Inc.

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

過敏性腸症候群治療市場：タイプ別、適応症別、薬剤クラス別、投与経路別、流通チャネル別、地域別

Irritable Bowel Syndrome Treatment Market, By Type, By Indication, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

市場力学：

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章過敏性腸症候群治療の世界市場、タイプ別、2020年～2032年

第5章過敏性腸症候群治療の世界市場、適応症別、2020年～2032年

第6章過敏性腸症候群治療の世界市場、薬剤クラス別、2020年～2032年

第7章過敏性腸症候群治療の世界市場、投与経路別、2020年～2032年

第8章過敏性腸症候群治療の世界市場、流通チャネル別、2020年～2032年

第9章過敏性腸症候群治療の世界市場、地域別、2020年～2032年

第10章競合情勢

第11章アナリストの推奨事項

第12章参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Irritable Bowel Syndrome Treatment Market, By Type, 2020-2032, (USD Bn)

5. Global Irritable Bowel Syndrome Treatment Market, By Indication, 2020-2032, (USD Bn)

6. Global Irritable Bowel Syndrome Treatment Market, By Drug Class, 2020-2032, (USD Bn)

7. Global Irritable Bowel Syndrome Treatment Market, By Route of Administration, 2020-2032, (USD Bn)

8. Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)

9. Global Irritable Bowel Syndrome Treatment Market, By Region, 2020 - 2032, Value (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

過敏性腸症候群治療市場：タイプ別、適応症別、薬剤クラス別、投与経路別、流通チャネル別、地域別

Irritable Bowel Syndrome Treatment Market, By Type, By Indication, By Drug Class, By Route of Administration, By Distribution Channel, By Geography

市場力学：

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 過敏性腸症候群治療の世界市場、タイプ別、2020年～2032年

第5章 過敏性腸症候群治療の世界市場、適応症別、2020年～2032年

第6章 過敏性腸症候群治療の世界市場、薬剤クラス別、2020年～2032年

第7章 過敏性腸症候群治療の世界市場、投与経路別、2020年～2032年

第8章 過敏性腸症候群治療の世界市場、流通チャネル別、2020年～2032年

第9章 過敏性腸症候群治療の世界市場、地域別、2020年～2032年

第10章 競合情勢

第11章 アナリストの推奨事項

第12章 参考文献と調査手法

Market Dynamics:

Key Features of the Study:

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Irritable Bowel Syndrome Treatment Market, By Type, 2020-2032, (USD Bn)

5. Global Irritable Bowel Syndrome Treatment Market, By Indication, 2020-2032, (USD Bn)

6. Global Irritable Bowel Syndrome Treatment Market, By Drug Class, 2020-2032, (USD Bn)

7. Global Irritable Bowel Syndrome Treatment Market, By Route of Administration, 2020-2032, (USD Bn)

8. Global Irritable Bowel Syndrome Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)

9. Global Irritable Bowel Syndrome Treatment Market, By Region, 2020 - 2032, Value (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章過敏性腸症候群治療の世界市場、タイプ別、2020年～2032年

第5章過敏性腸症候群治療の世界市場、適応症別、2020年～2032年

第6章過敏性腸症候群治療の世界市場、薬剤クラス別、2020年～2032年

第7章過敏性腸症候群治療の世界市場、投与経路別、2020年～2032年

第8章過敏性腸症候群治療の世界市場、流通チャネル別、2020年～2032年

第9章過敏性腸症候群治療の世界市場、地域別、2020年～2032年

第10章競合情勢

第11章アナリストの推奨事項

第12章参考文献と調査手法